AC
BMY icon

Alley Company’s Bristol-Myers Squibb BMY Stock Holding History

Alley Company’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-90,953
Closed -$5.57M – 81
2017
Q4 		$5.57M Buy
90,953
+4,413
+5% +$276K 1.91% 17
2017
Q3 		$5.52M Buy
86,540
+87
+0.1% +$5.08K 2% 17
2017
Q2 		$4.82M Buy
86,453
+1,557
+2% +$84.7K 1.82% 20
2017
Q1 		$4.62M Buy
84,896
+5,757
+7% +$316K 1.82% 22
2016
Q4 		$4.63M Sell
79,139
-1,621
-2% -$88.6K 2.03% 16
2016
Q3 		$4.36M Buy
80,760
+2,073
+3% +$133K 1.94% 17
2016
Q2 		$5.79M Buy
78,687
+1,634
+2% +$115K 2.63% 9
2016
Q1 		$4.92M Buy
77,053
+565
+0.7% +$35.6K 2.36% 10
2015
Q4 		$5.26M Buy
76,488
+1,100
+1% +$72.7K 2.57% 7
2015
Q3 		$4.46M Buy
75,388
+1,551
+2% +$98.4K 2.3% 10
2015
Q2 		$4.91M Sell
73,837
-461
-0.6% -$30.4K 2.42% 6
2015
Q1 		$4.79M Buy
74,298
+3,841
+5% +$240K 2.35% 5
2014
Q4 		$4.16M Buy
70,457
+4,109
+6% +$232K 2.14% 12
2014
Q3 		$3.4M Buy
66,348
+1,264
+2% +$63.1K 2.45% 9
2014
Q2 		$3.16M Sell
65,084
-3,435
-5% -$169K 2.25% 9
2014
Q1 		$3.56M Buy
68,519
+5,464
+9% +$291K 2.51% 6
2013
Q4 		$3.35M Buy
63,055
+21,057
+50% +$1.07M 2.43% 8
2013
Q3 		$1.94M Buy
41,998
+1,786
+4% +$78.4K 1.55% 29
2013
Q2 		$1.8M Buy
+40,212
New +$1.75M 1.5% 31

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alley Company's BMY Position: Q1 2018 in Review

Alley Company sold out of Bristol-Myers Squibb (BMY) in Q1 2018, closing a stake of 90,953 shares — an estimated $5.57M sold.

Alley Company first reported a position in BMY in Q2 2013 and held it in 19 quarters. The position peaked at $5.79M in Q2 2016. 1,746 funds tracked by Wall St. Rank hold BMY as of Q1 2018.

  • Alley Company reported no remaining Bristol-Myers Squibb position as of Q1 2018 after selling out during the quarter.
  • Alley Company sold 90,953 Bristol-Myers Squibb shares in Q1 2018, an estimated $5.57M.
  • Alley Company first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 19 quarters.
  • Alley Company's Bristol-Myers Squibb position peaked at $5.79M in Q2 2016.
  • 1,746 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2018.

Based on Alley Company's 13F filing for Q1 2018, filed 27 Apr 2018.